Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Nature Medicine|July 21, 2015
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myelomaAaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, et al.
Blood Cancer Discovery|November 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyAlfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder WorkshopsSimon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International|May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular diseaseSimon A Carter, Charlotte Logeman, Martin Howell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2018
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura H Mariani, Andrew S Bomback, Pietro A Canetta, et al.
The New England Journal of Medicine|August 22, 2019
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple MyelomaAjai Chari, Dan T Vogl, Maria Gavriatopoulou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2013
Salvage second hematopoietic cell transplantation in myelomaLaura C Michaelis, Ayman Saad, Xiaobo Zhong, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Pageof 11